IP Library › Granted Patent US 12,691,298
Granted Patent B2
US 12,691,298 · App. 17/750,872 · Granted Jul 28, 2026

Phototherapy devices for treatment of dermatological disorders of the scalp

Inventors: Nicholas William Medendorp, Jr. (Raleigh, NC); Gerald H. Negley (Chapel Hill, NC); Matthew C. Reynolds (Chapel Hill, NC); James Michael Lay (Apex, NC)
Assignee: KNOW Bio, LLC
A61N5/0616A61B2018/00642A61B2018/00791A61B2090/033A61B2090/061A61B2090/065A61B2090/0804A61B2090/0814A61N5/0617A61N2005/063A61N2005/0633A61N2005/0647A61N2005/0652A61N2005/0662
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,691,298
App. No.
17/750,872
Filed
May 23, 2022
Granted
Jul 28, 2026
Kind
B2
Art Unit
3796
USPC
607/91
Abstract

Modulated light therapy devices for treatment of dermatological disorders of the scalp are provided. An exemplary device includes a flexible printed circuit board (FPCB) supporting at least one light emitting device having an emitter height. The FPCB includes multiple interconnected panels and bending regions defined in and between at least some of the interconnected panels as to allow the FPCB to be configured in a concave shape to cover at least a portion of a cranial vertex of the patient. At least one light-transmissive layer proximate to the FPCB is configured to transmit (e.g., incoherent) light emissions generated by at least one light emitting device. At least one standoff is configured to be arranged between the FPCB and the scalp of the patient, wherein the at least one standoff includes a standoff height that exceeds the emitter height.

Claims (30)

1 . A phototherapy device for delivering light emissions to a scalp of a patient, the phototherapy device comprising:

a flexible substrate comprising a proximal surface and a distal surface that is opposite the proximal surface, the proximal surface supporting an array of light emitting devices configured to generate light having a peak wavelength in a range from 600 nanometers (nm) to 700 nm;

driver circuitry and a microcontroller arranged on the distal surface in a position that is opposite at least a portion of the array of light emitting devices;

a proximity sensor on the proximal surface of the flexible substrate and configured to provide an input to the microcontroller to trigger the driver circuitry to at least one of initiate, terminate, or modify operation of the array of light emitting devices; and

a signal guard on the distal surface of the flexible substrate in a position opposite a sensing direction of the proximity sensor.

2 . The phototherapy device of claim 1 , wherein the array of light emitting devices is arranged to generate light having a first peak wavelength in a range from 615 nm to 635 nm.

3 . The phototherapy device of claim 1 , wherein the proximity sensor is arranged to sense a condition indicative of placement of the phototherapy device proximate to the scalp of the patient and generate an output signal to trigger the driver circuitry to at least one of initiate, terminate, or modify operation of the array of light emitting devices.

4 . The phototherapy device of claim 1 , wherein the proximity sensor is a capacitive sensor.

5 . The phototherapy device of claim 4 , wherein the capacitive sensor comprises a capacitive touch active pad.

6 . The phototherapy device of claim 5 , wherein the signal guard is on a tab of the flexible substrate and the signal guard and the capacitive touch active pad are aligned within one another when the tab is bent toward a remainder of the flexible substrate.

7 . The phototherapy device of claim 5 , wherein the signal guard is configured to be driven in polarity opposite from the capacitive touch active pad.

8 . The phototherapy device of claim 5 , wherein the signal guard is larger in size than the capacitive touch active pad.

9 . The phototherapy device of claim 1 , wherein the driver circuitry is part of an electronics subassembly that is configured for wireless communication with an external electronic device.

10 . A phototherapy device for delivering light emissions to a scalp of a patient, the phototherapy device comprising:

a flexible substrate comprising a proximal surface and a distal surface that is opposite the proximal surface, the proximal surface supporting a first array of light emitting devices configured to generate light having a first peak wavelength in a range from 600 nanometers (nm) to 700 nm;

a control printed circuit board comprising driver circuitry arranged on the distal surface in a position that is opposite at least a portion of the first array of light emitting devices, the driver circuitry configured to drive the first array of light emitting devices;

a covering arranged to cover the flexible substrate, the covering forming an electronics receptacle arranged to receive the driver circuitry;

an electronic connection port extending through the covering, the electronic connection port being mechanically attached to the electronics receptacle;

a proximity sensor on the proximal surface of the flexible substrate and configured to provide an input to trigger the driver circuitry to at least one of initiate, terminate, or modify operation of the first array of light emitting devices; and

a signal guard on the distal surface of the flexible substrate in a position opposite a sensing direction of the proximity sensor.

11 . The phototherapy device of claim 10 , wherein the first array of light emitting devices is arranged to generate light having a first peak wavelength in a range from 615 nm to 635 nm.

12 . The phototherapy device of claim 11 , wherein the first array of light emitting devices further comprises a second array of light emitting devices arranged to generate light having a second peak wavelength, wherein the second peak wavelength differs from the first peak wavelength by at least 20 nm.

13 . The phototherapy device of claim 12 , wherein the second peak wavelength is in a range of from 650 nm to 670 nm.

14 . The phototherapy device of claim 10 , wherein the control printed circuit board and the driver circuitry are part of an electronics subassembly on the distal surface and the electronics receptacle is arranged to receive the electronics subassembly.

15 . The phototherapy device of claim 14 , wherein the electronics subassembly comprises an energy storage element that is in electrical communication with the driver circuitry.

16 . The phototherapy device of claim 14 , wherein the electronic connection port is electrically coupled to the electronics subassembly.

17 . The phototherapy device of claim 16 , further comprising a seal plug that is removably attached to the electronic connection port.

18 . The phototherapy device of claim 16 , wherein the electronic connection port is configured to receive one or more of electrical power and electronic data from an external electronic device.

19 . The phototherapy device of claim 14 , wherein the electronics subassembly is configured for wireless communication with an external electronic device.

20 . The phototherapy device of claim 10 , wherein the proximity sensor is a capacitive sensor.

Continuity (4)
Continuation 16884858 · May 27, 2020
Continuation 15222292 · Jul 28, 2016
Provisional Application 62197736 · Jul 28, 2015
Related Publication 20220280809A1 · Sep 8, 2022
References Cited (233)
US 2333987A · Dandy · 1943 [cited by applicant]
US 5228431A · Giarretto · 1993 [cited by applicant]
US 5549639A · Ross · 1996 [cited by applicant]
US 5616140A · Prescott · 1997 [cited by applicant]
US 5913883A · Alexander et al. · 1999 [cited by applicant]
US 6096066A · Chen et al. · 2000 [cited by applicant]
US 6171332B1 · Whitehurst · 2001 [cited by applicant]
US 6283956B1 · McDaniel · 2001 [cited by applicant]
US 6290713B1 · Russell · 2001 [cited by applicant]
US 6424338B1 · Anderson · 2002 [cited by examiner]
US 6443978B1 · Zharov · 2002 [cited by applicant]
US 6497719B2 · Pearl et al. · 2002 [cited by applicant]
US 6645230B2 · Whitehurst · 2003 [cited by applicant]
US 6663659B2 · McDaniel · 2003 [cited by applicant]
US 6676655B2 · McDaniel · 2004 [cited by applicant]
US 6887260B1 · McDaniel · 2005 [cited by applicant]
US 6918922B2 · Yon · 2005 [cited by applicant]
US 6936044B2 · McDaniel · 2005 [cited by applicant]
US 6955684B2 · Savage, Jr. et al. · 2005 [cited by applicant]
US 6989023B2 · Black · 2006 [cited by applicant]
US 7201764B2 · Pearl et al. · 2007 [cited by applicant]
US 7201765B2 · McDaniel · 2007 [cited by applicant]
US 7267673B2 · Pilcher et al. · 2007 [cited by applicant]
US 7303578B2 · De Taboada et al. · 2007 [cited by applicant]
US 7304201B2 · Holloway et al. · 2007 [cited by applicant]
US 7309348B2 · Streeter et al. · 2007 [cited by applicant]
US 7494503B2 · McDaniel · 2009 [cited by applicant]
US D599954S · Michaels et al. · 2009 [cited by applicant]
US D631604S · Michaels et al. · 2011 [cited by applicant]
US D635686S · Tucker et al. · 2011 [cited by applicant]
US D639751S · Tucker et al. · 2011 [cited by applicant]
US D640793S · Britt · 2011 [cited by applicant]
US 8053977B2 · Lifka et al. · 2011 [cited by applicant]
US 8146607B2 · Rabin et al. · 2012 [cited by applicant]
US 8192473B2 · Tucker et al. · 2012 [cited by applicant]
US 8252033B2 · Tucker et al. · 2012 [cited by applicant]
US 8518029B2 · Birmingham et al. · 2013 [cited by applicant]
US 8556951B2 · Witt et al. · 2013 [cited by applicant]
US 8641702B2 · Pilcher et al. · 2014 [cited by applicant]
US 8651111B2 · McDaniel · 2014 [cited by applicant]
US 8747446B2 · Chen et al. · 2014 [cited by applicant]
US 8758215B2 · Legendre et al. · 2014 [cited by applicant]
US 8771327B2 · Pearl et al. · 2014 [cited by applicant]
US 8807131B1 · Tunnell et al. · 2014 [cited by applicant]
US D712561S · Hagenauer · 2014 [cited by applicant]
US 8845704B2 · Dunning et al. · 2014 [cited by applicant]
US D716493S · Michaels et al. · 2014 [cited by applicant]
US 8900282B2 · Brawn · 2014 [cited by applicant]
US 8900283B2 · Johnson et al. · 2014 [cited by applicant]
US 9017391B2 · McDaniel · 2015 [cited by applicant]
US 9040103B2 · Marrot et al. · 2015 [cited by applicant]
US 9132279B2 · Roersma et al. · 2015 [cited by applicant]
US 9144690B2 · McDaniel · 2015 [cited by applicant]
US 9192780B2 · McDaniel · 2015 [cited by applicant]
US 9215921B2 · Thiebaut et al. · 2015 [cited by applicant]
US 9227082B2 · McDaniel · 2016 [cited by applicant]
US D754897S · Michaels et al. · 2016 [cited by applicant]
US 9308389B2 · Brawn · 2016 [cited by applicant]
US 9415237B2 · Wagenaar Cacciola et al. · 2016 [cited by applicant]
US D777339S · Chen · 2017 [cited by applicant]
US 9545524B2 · Maas et al. · 2017 [cited by applicant]
US 9554963B2 · Pilcher et al. · 2017 [cited by applicant]
US 9561386B2 · Pearl et al. · 2017 [cited by applicant]
US 9616013B2 · Casasanta, III et al. · 2017 [cited by applicant]
US 9636522B2 · Oversluizen et al. · 2017 [cited by applicant]
US 9724536B1 · Rabin et al. · 2017 [cited by applicant]
US D804047S · Michaels et al. · 2017 [cited by applicant]
US D849959S · Lay et al. · 2019 [cited by applicant]
US 10525275B2 · Stasko et al. · 2020 [cited by applicant]
US D935040S · Lay et al. · 2021 [cited by applicant]
US 20020128648A1 · Weber et al. · 2002 [cited by applicant]
US 20030076281A1 · Morgan et al. · 2003 [cited by applicant]
US 20030130709A1 · D.C et al. · 2003 [cited by applicant]
US 20030167080A1 · Hart et al. · 2003 [cited by applicant]
US 20030236487A1 · Knowlton · 2003 [cited by applicant]
US 20040044384A1 · Leber et al. · 2004 [cited by applicant]
US 20040073079A1 · Altshuler et al. · 2004 [cited by applicant]
US 20040162549A1 · Altshuler · 2004 [cited by applicant]
US 20040162596A1 · Altshuler et al. · 2004 [cited by applicant]
US 20050045189A1 · Jay · 2005 [cited by applicant]
US 20050070977A1 · Molina · 2005 [cited by applicant]
US 20050143792A1 · Jay · 2005 [cited by applicant]
US 20050182460A1 · Kent · 2005 [cited by examiner]
US 20060095099A1 · Shanks et al. · 2006 [cited by applicant]
US 20060227844A1 · Guenter · 2006 [cited by applicant]
US 20060258896A1 · Haber et al. · 2006 [cited by applicant]
US 20060287696A1 · Wright et al. · 2006 [cited by applicant]
US 20070060819A1 · Altshuler et al. · 2007 [cited by applicant]
US 20070073366A1 · Porco · 2007 [cited by applicant]
US 20070106856A1 · Nomura et al. · 2007 [cited by applicant]
US 20070179571A1 · De Taboada et al. · 2007 [cited by applicant]
US 20070185553A1 · Kennedy · 2007 [cited by applicant]
US 20070208395A1 · Leclerc · 2007 [cited by examiner]
US 20070208396A1 · Whatcott et al. · 2007 [cited by applicant]
US 20070213792A1 · Yaroslavsky et al. · 2007 [cited by applicant]
US 20070233208A1 · Kurtz et al. · 2007 [cited by applicant]
US 20070248930A1 · Brawn · 2007 [cited by applicant]
US 20080033516A1 · Altshuler et al. · 2008 [cited by applicant]
US 20080269849A1 · Lewis · 2008 [cited by examiner]
US 20080319430A1 · Zenzie et al. · 2008 [cited by applicant]
US 20090177256A1 · Ripper et al. · 2009 [cited by applicant]
US 20090254156A1 · Powell et al. · 2009 [cited by applicant]
US 20090318802A1 · Boyden et al. · 2009 [cited by applicant]
US 20090319008A1 · Mayer · 2009 [cited by applicant]
US 20100004645A1 · Jeong et al. · 2010 [cited by applicant]
US 20100049180A1 · Wells et al. · 2010 [cited by applicant]
US 20100076529A1 · Tucker et al. · 2010 [cited by applicant]
US 20100106077A1 · Rabin · 2010 [cited by examiner]
US 20100204762A1 · De Taboada et al. · 2010 [cited by applicant]
US 20100242155A1 · Carullo, Jr. · 2010 [cited by applicant]
US 20100289506A1 · Moon · 2010 [cited by examiner]
US 20100331928A1 · Dunning et al. · 2010 [cited by applicant]
US 20110015707A1 · Tucker et al. · 2011 [cited by applicant]
US 20110054573A1 · Mitchell · 2011 [cited by applicant]
US 20110144410A1 · Kennedy · 2011 [cited by applicant]
US 20110144727A1 · Benedict · 2011 [cited by applicant]
US 20110160814A2 · Tucker et al. · 2011 [cited by applicant]
US 20110264174A1 · McNeill et al. · 2011 [cited by applicant]
US 20110301673A1 · Hoffer et al. · 2011 [cited by applicant]
US 20120059440A1 · Hamid · 2012 [cited by applicant]
US 20120065709A1 · Dunning et al. · 2012 [cited by applicant]
US 20120283711A1 · Liu et al. · 2012 [cited by applicant]
US 20130041432A1 · Tucker et al. · 2013 [cited by applicant]
US 20130066404A1 · Tapper et al. · 2013 [cited by applicant]
US 20130090873A1 · Lundstrum · 2013 [cited by examiner]
US 20130131762A1 · Oversluizen et al. · 2013 [cited by applicant]
US 20130144364A1 · Wagenaar Cacciola et al. · 2013 [cited by applicant]
US 20140074193A1 · Luzon · 2014 [cited by examiner]
US 20140128941A1 · Williams · 2014 [cited by applicant]
US 20140128942A1 · Bembridge et al. · 2014 [cited by applicant]
US 20140148879A1 · Mersch · 2014 [cited by applicant]
US 20140243933A1 · Ginggen · 2014 [cited by applicant]
US 20140276248A1 · Hall et al. · 2014 [cited by applicant]
US 20140303693A1 · Haarlander et al. · 2014 [cited by applicant]
US 20140330196A1 · Ingman et al. · 2014 [cited by applicant]
US 20140350643A1 · Pepitone et al. · 2014 [cited by applicant]
US 20150005854A1 · Said · 2015 [cited by examiner]
US 20150013214A1 · Isserow et al. · 2015 [cited by applicant]
US 20150112411A1 · Beckman et al. · 2015 [cited by applicant]
US 20150127072A1 · Pomar · 2015 [cited by applicant]
US 20150134033A1 · Tapper et al. · 2015 [cited by applicant]
US 20150297914A1 · Hamid et al. · 2015 [cited by applicant]
US 20160038763A1 · Tapper et al. · 2016 [cited by applicant]
US 20160051835A1 · Tapper et al. · 2016 [cited by applicant]
US 20160106999A1 · Michaels et al. · 2016 [cited by applicant]
US 20160271420A1 · Pina · 2016 [cited by examiner]
US 20160310757A1 · Pepitone et al. · 2016 [cited by applicant]
US 20160325109A1 · Knaus et al. · 2016 [cited by applicant]
US 20160360161A1 · Fitzgerald · 2016 [cited by applicant]
US 20170028216A1 · Medendorp, Jr. et al. · 2017 [cited by applicant]
US 20190262567A1 · Davis · 2019 [cited by applicant]
US 20200221994A1 · Kumpan-Bahrami · 2020 [cited by applicant]
US 20220152417A1 · Kim · 2022 [cited by applicant]
US 20220176148A1 · Hetz · 2022 [cited by applicant]
AU 2016100390A4 · 2016 [cited by applicant]
CN 101687101A · 2010 [cited by applicant]
CN 102247656A · 2011 [cited by applicant]
CN 102348425A · 2012 [cited by applicant]
CN 203169848U · 2013 [cited by applicant]
CN 103930162A · 2014 [cited by applicant]
CN 204317834U · 2015 [cited by applicant]
EP 2508229A1 · 2012 [cited by applicant]
EP 3069762A1 · 2016 [cited by applicant]
IN 102380169A · 2012 [cited by applicant]
KR 101823123B1 · 2018 [cited by applicant]
KR 20190018383A · 2019 [cited by applicant]
WO 2004033040A1 · 2004 [cited by applicant]
WO 2008131343A1 · 2008 [cited by applicant]
WO 2008144157A1 · 2008 [cited by applicant]
WO 2013036558A1 · 2013 [cited by applicant]
WO 2014146029A1 · 2014 [cited by applicant]
WO 2015006309A1 · 2015 [cited by applicant]
WO 2020040435A1 · 2020 [cited by applicant]
WO 2023080582A1 · 2023 [cited by applicant]
Notice of Allowance for Brazilian Patent Application No. BR112018001857-0, mailed Sep. 6, 2022, 6 pages. [cited by applicant]
Abeyakirthi, Sharnika, “Nitric oxide,” DermNet NZ, 2009,4 pages, http://www.dermnetnz.org/topics/nitric-oxide/. [cited by applicant]
Adamskaya, Natalia et al., “Light therapy by blue LED improves wound healing in an excision model in rats,” Injury, 2010, 5 pages. [cited by applicant]
Andrew, Penelope J. et al., “Enzymatic function of nitric oxide synthases,” Cardiovascular Research, vol. 43, No. 3, Aug. 15, 1999, pp. 521-531. [cited by applicant]
Author Unknown, “Brilliant Light Therapy,” In Light Wellness Systems, eBrochure, Date Unknown, 5 pages. [cited by applicant]
Author Unknown, “Healed by Light,” Digi-Key Electronics, Jul. 1, 2014, 4 pages, www.digikey.com/es/rticles/techzone/2014/jul/healed-by-light. [cited by applicant]
Author Unknown, “illuMask,” La Lumiere, Date Unknown, 2 pages, http://www.illumask.com/dimming/. [cited by applicant]
Author Unknown, “IPL Hair Removal,” Spectrum Science & Beauty, Spectrum Blog, Sep. 16, 2014, 3 Pages, http://www.spectrumsciencebeauty.com.au/ipl-hair-removal/#prettyPhoto. [cited by applicant]
Author Unknown, “Near-IR Photoluminescent Dyes for Molecular Labeling,” NanoQuantum, Technology, 2013, 7 pages, http://www.nanoquantum.com/Technology.html. [cited by applicant]
Author Unknown, “Philips Blue Touch,” Koninklijke Philips NV., Version 1.0.1, Sep. 1, 2013, 2 pages. [cited by applicant]
Author Unknown, “Theradome Laser Helmet Review—A 120 Day Continuous Journal,” Prevent Hair Loss Products, Jan. 14, 2014, retrieved Jun. 27, 2017, https://web.archive.org/web/20140610024017/http://preventhairlossproducts… [cited by applicant]
Author Unknown, “Ultraviolet Light Therapy,” Wound Care Centers, Date Unknown, 3 pages, http://www.woundcarecenters.org/article/wound-therapies/ultraviolet-light-therapy. [cited by applicant]
Author Unknown, “What is Light Therapy used for?” Rio, The Dezac Group, Ltd, Date Unknown, 4 pages, http://www.lightmask.com/uses_for_It.htm#top. [cited by applicant]
Avci, Pinar et al., “Low-Level Laser {Light) Therapy {LLL T) for Treatment of Hair Loss,” Lasers in Surgery and Medicine, vol. 46, 2014, pp. 144-151. [cited by applicant]
Avci, Pinar et al., “Low-Level Laser {Light) Therapy {LLL T) in Skin: Stimulating, Healing, Restoring,” Seminars in Cutaneous Medicine and Surgery, vol. 32, No. 1, 2013, pp. 41-52. [cited by applicant]
Ball, Kerri A. et al., “Low intensity light stimulates nitrite-dependent nitric oxide synthesis but not oxygen consumption by cytochrome c oxidase: Implications for phototherapy,” Journal of Photochemistry and Photobiol… [cited by applicant]
Barolet, Daniel, “Light-Emitting Diodes (LEOs) in Dermatology,” Seminars in Cutaneous Medicine and Surgery, vol. 27, No. 4, Dec. 1, 2008, pp. 227-238. [cited by applicant]
Cals-Grierson, M.-M. et al., “Nitric oxide function in the skin,” Nitric Oxide, vol. 10, No. 4, Jun. 2004, pp. 179-193. [cited by applicant]
Chaves, Maria Emilia De Abreu et al., “Effects of low-power light therapy on wound healing: Laser x LED,” Anais Brasileiros de Dermatologia, vol. 89, No. 4, Jul./Aug. 2014, pp. 616-623. [cited by applicant]
Farivar, Shirin et al., “Biological Effects of Low Level Laser Therapy,” Journal of Lasers in Medical Sciences, vol. 5, No. 2, Spring 2014, pp. 58-62. [cited by applicant]
Feelisch, Martin et al., “Concomitant S-, N-, and heme-nitrosis(yl)ation in biological tissues and fluids: implications for the fate of NO in vivo,” FASEB, vol. 16, No. 13, Nov. 2002, pp. 1775-1785. [cited by applicant]
Gupta, Asheesh et al., “History and Fundamentals of Low-Level Laser {Light) Therapy,” Handbook of Dhotomedicine, Chapter 5, CRC Press, 2014, pp. 43-52. [cited by applicant]
Hamblin, Michael, et al., “Mechanisms of Low Level Light Therapy,” Proceedings of the SPIE, vol. 6140, Feb. 10, 2006, pp. 614001-1 to 641001-12. [cited by applicant]
Hamblin, Michael R, “Mechanisms of Low Level Light Therapy,” Aug. 14, 2008, 22 pages, http://photobiology_info/Hamblin.html. [cited by applicant]
Hamblin, Michael R, The Role of Nitric Oxide in Low Level Light Therapy, Proceedings of SPIE, vol. 6846, 2008, p. 684602-1 to 684602-14. [cited by applicant]
Karu, Tiina I., “Low-Power Laser Therapy,” Biomedical Photonics Handbook, Chapter 48, CRC Press, 2003, pp. 48-1 to 48-25. [cited by applicant]
Kirima, Kazuyoshi et al., “Evaluation of systemic blood NO dynamics by EPR spectroscopy: HbNO as an endogenous index of NO,” American Journal of Physiology Heart and Circulatory Physiology, vol. 285, No. 2, Aug. 2003, p… [cited by applicant]
Kovacs, Izabella et al., “Nitric oxide-based protein modification: formation and site-specificity of protein~itrosylation,” Frontiers in Plant Science, vol. 4, Article 137, May 14, 2013, 10 pages. [cited by applicant]
Leong, Mimi, “Effects of Light-Emitiing Diode Photostimulation on Burn Wound Healing,” hesis, The University of Texas Graduate School of Biomedical Sciences at Galveston, May 2006, 92 pages. [cited by applicant]
Mandel, Arkady, et al., “A renaissance in low-level laser {light) therapy- LLLT,” Photonics and Lasers in Medicine, vol. 1, No. 4, Nov. 2012, pp. 231-234. [cited by applicant]
Martin, Richard, “Laser-Accelerated Inflammation/Pain Reduction and Healing,” Practical Pain Management, vol. 3, No. 6, Nov./Dec. 2003, pp. 20-25. [cited by applicant]
Phurrough, Steve et al., “Decision Memo for Infrared Therapy Devices {CAG-00291 N),” Centers for Medicare & Medicaid Services, Oct. 24, 2006, 37 pages. [cited by applicant]
Poyton, Roberto et al., “Therapeutic Photobiomodulation: Nitric Oxide and a Novel Function of Mitochondrial :;ytochrome C Oxidase,” Discovery Medicine, Feb. 20, 2011, 11 pages. [cited by applicant]
Sarti, Paolo et al., “The Chemical Interplay between Nitric Oxide and Mitochondrial Cytochrome c Oxidase: Reactions, Effectors and Pathophysiology,” International Journal of Cell Biology, vol. 2012, Article 571067, 2012… [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 15/222,292, mailed Aug. 6, 2019, 13 pages. [cited by applicant]
Notice of Allowance and Examiner-Initiated Interview Summary for U.S. Appl. No. 15/222,292, mailed Feb. 25, 2020, 9 pages. [cited by applicant]
Extended European Search Report for European Patent Application No. 20194978.1, mailed Jun. 2, 2021, 14 pages. [cited by applicant]
International Search Report and Written Opinion for PCT/US2016/44403, mailed Dec. 16, 2016, 11 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 16/884,858, mailed Mar. 9, 2022, 7 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 16/884,858, mailed Sep. 1, 2021, 14 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 16/884,858, mailed Dec. 21, 2021, 16 pages. [cited by applicant]
Office Action for Chinese Patent Application No. 201680054311.3, mailed Dec. 20, 2021, 27 pages. [cited by applicant]
Notification to Grant for Chinese Patent Application No. 201680054311.3, mailed Jan. 14, 2022, 3 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 17/325,618, mailed May 31, 2023, 15 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 17/325,618, mailed Sep. 14, 2023, 12 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/315,795, mailed Dec. 20, 2023, 17 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/315,819, mailed Dec. 21, 2023, 16 pages. [cited by applicant]
Advisory Action and Examiner-Initiated Interview Summary for U.S. Appl. No. 17/325,618, mailed Nov. 17, 2023, 4 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/325,618, mailed Jan. 9, 2023, 9 pages. [cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US2023/072693, mailed Nov. 21, 2023, 12 pages. [cited by applicant]
Notice of Allowance for U.S. Appl. No. 17/325,618, mailed Jan. 9, 2024, 9 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/315,795, mailed Jun. 20, 2024, 21 pages. [cited by applicant]
Final Office Action for U.S. Appl. No. 18/315,819, mailed Jun. 5, 2024, 20 pages. [cited by applicant]
Applicant-Initiated Interview Summary for U.S. Appl. No. 18/315,819, mailed Aug. 1, 2024, 2 pages. [cited by applicant]
Advisory Action and Examiner-Initiated Interview Summary for U.S. Appl. No. 18/315,795, mailed Aug. 29, 2024, 4 pages. [cited by applicant]
Advisory Action and Examiner-Initiated Interview Summary for U.S. Appl. No. 18/315,819, mailed Aug. 15, 2024, 4 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/315,819, mailed Oct. 1, 2024, 16 pages. [cited by applicant]
Non-Final Office Action for U.S. Appl. No. 18/315,795, mailed Nov. 21, 2024, 19 pages. [cited by applicant]
Gentile, et al., “A randomized blinded retrospective studdy: the combined use of micro-needling technique, low-level laser therapy and autologous non-activated platelet-rich plasma improves hair re-growth in patients wi… [cited by applicant]